Quick Answer
Vicarious Surgical Inc. reported Net Income of -$50.18 million for fiscal year 2025.
Vicarious Surgical Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$50.18M +20.6% |
-$63.22M +11.0% |
-$71.07M -1478.1% |
$5.16M +114.6% |
-$35.21M -173.5% |
-$12.88M |
| Diluted EPS | — | — | -$0.49 -1325.0% |
$0.04 +111.1% |
-$0.36 | — |
| Total Assets | $19.58M -71.1% |
$67.72M -43.5% |
$119.86M -14.6% |
$140.29M -22.8% |
$181.68M +921.4% |
$17.79M |
| Cash and Equivalents | $2.57M -73.6% |
$9.74M -81.6% |
$52.82M -54.5% |
$116.21M -33.0% |
$173.51M +928.7% |
$16.87M |
| Long-Term Debt | — | — | — | — | $675.0K | — |
| Stockholders Equity | $9.84M -78.9% |
$46.70M -52.3% |
$97.97M -11.8% |
$111.05M +33.6% |
$83.09M +378.7% |
-$29.82M -70.2% |
| R&D Expense | $33.60M -16.3% |
$40.16M -15.6% |
$47.58M +8.4% |
$43.90M +99.0% |
$22.06M +125.2% |
$9.80M |
| Operating Income | -$50.03M +24.8% |
-$66.56M +17.5% |
-$80.67M -0.7% |
-$80.08M -109.5% |
-$38.22M -194.4% |
-$12.98M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$11.06M | +35.3% | +16.3% |
| Diluted EPS | June 30, 2024 | -$2.59 | +28.5% | -2490.0% |
| Total Assets | September 30, 2025 | $29.35M | -63.6% | -28.2% |
| Cash and Equivalents | September 30, 2025 | $3.16M | -55.2% | -19.1% |
| Long-Term Debt | September 30, 2022 | $250.0K | -70.1% | -36.2% |
| Stockholders Equity | September 30, 2025 | $14.09M | -75.7% | -38.9% |
| R&D Expense | September 30, 2025 | $7.99M | -26.0% | -11.7% |
| Operating Income | September 30, 2025 | -$11.50M | +35.2% | +14.9% |
- Vicarious Surgical Inc. reported Net Income of -$50.18 million for fiscal year 2025.
- Vicarious Surgical Inc. showed an increase of +20.6% in Net Income compared to the prior fiscal year.
- Vicarious Surgical Inc. reported Diluted EPS of $0.49 per share (loss) for fiscal year 2023.
- Vicarious Surgical Inc. showed a decrease of -1325.0% in Diluted EPS compared to the prior fiscal year.
- Vicarious Surgical Inc. reported Total Assets of $19.58 million for fiscal year 2025.
- Vicarious Surgical Inc. showed a decrease of -71.1% in Total Assets compared to the prior fiscal year.
- Vicarious Surgical Inc. reported Cash and Equivalents of $2.57 million for fiscal year 2025.
- Vicarious Surgical Inc. showed a decrease of -73.6% in Cash and Equivalents compared to the prior fiscal year.
- Vicarious Surgical Inc. reported Long-Term Debt of $675.0 thousand for fiscal year 2021.
- Vicarious Surgical Inc. reported Stockholders Equity of $9.84 million for fiscal year 2025.
- Vicarious Surgical Inc. showed a decrease of -78.9% in Stockholders Equity compared to the prior fiscal year.
- Vicarious Surgical Inc. reported R&D Expense of $33.60 million for fiscal year 2025.
- Vicarious Surgical Inc. showed a decrease of -16.3% in R&D Expense compared to the prior fiscal year.
- Vicarious Surgical Inc. reported Operating Income of -$50.03 million for fiscal year 2025.
- Vicarious Surgical Inc. showed an increase of +24.8% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: